(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LONGEVITY BIOTECH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LONGEVITY BIOTECH

ST13

US500000097784579

Class

5, 42

Filing

97784579

Registration

8033225

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

43

Latest update

11/19/2025

Trademark type

Word

Nice classes

5, 42

Filing date

02/07/2023

Registration date

11/18/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/18/2025

Last transaction

11/19/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/31/2018

First use in commerce

12/31/2018

Drawing code

4

Owner type

03

Owner location

Philadelphia, PA

Examiner

CERDA,VICTOR

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Longevity Biotech, Inc.

Representatives

Jenifer deWolf Paine Fish & Richardson P.C.

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical products for the prevention and treatment of neurological disorders; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of diabetes; Pharmaceutical products for the treatment of autioimmune conditions; Pharmaceutical products for the immunomodulation therapeutic treatment of immune-mediated diseases

Class 42

Pharmaceutical research services; Laboratory research services relating to pharmaceuticals; Pharmaceutical product evaluation; Pharmaceutical products development

Publications

History of USPTO decisions and trademark events.

43 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/18/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

11/18/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/31/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/31/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/07/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/07/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/31/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/31/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/31/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/31/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/31/2025

HSCD

HIDDEN SENSITIVE CONTENT

05/13/2025

IUAF

USE AMENDMENT FILED

05/07/2025

EISU

TEAS STATEMENT OF USE RECEIVED

05/07/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/18/2025

EX1G

SOU EXTENSION 1 GRANTED

02/13/2025

EXT1

SOU EXTENSION 1 FILED

12/04/2024

EEXT

SOU TEAS EXTENSION RECEIVED

12/04/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

12/03/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/03/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/03/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/03/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/04/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/02/2024

PUBO

PUBLISHED FOR OPPOSITION

04/02/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/13/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/22/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/21/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/21/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/21/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

02/15/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/15/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/15/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/15/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/21/2023

GNRT

NON-FINAL ACTION E-MAILED

11/21/2023

CNRT

NON-FINAL ACTION WRITTEN

11/21/2023

DOCK

ASSIGNED TO EXAMINER

11/03/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/13/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/13/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/13/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/27/2023

NWAP

NEW APPLICATION ENTERED

02/10/2023

Continuous trademark protection

Get notified about every new filing that threatens LONGEVITY BIOTECH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.